Jasper Therapeutics Inc. (JSPR:NASDAQ) rocketted at $2.74, representing a gain of 476.4%. On Tue, Jan 03, 2023, JSPR:NASDAQ hit a New 2-Week High of $2.74. The stock appeared on our News Catalysts scanner on Tue, Jan 03, 2023 at 08:24 AM in the 'BIOTECH' category. From Tue, Dec 20, 2022, the stock recorded 62.50% Up Days and 66.67% Green Days
The stock spiked on Tue, Jan 03, 2023 at $3.8 with a volume of 62M+.
About Jasper Therapeutics Inc. (JSPR:NASDAQ)
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy.
Top 10 Gainers:
- Jasper Therapeutics Inc. (JSPR:NASDAQ), 476.36%
- Lucira Health Inc. (LHDX:NASDAQ), 440.05%
- Horizon Global Corporation (HZN:NYSE), 342.39%
- Vivos Therapeutics Inc. (VVOS:NASDAQ), 84.08%
- Gelesis Holdings Inc. (GLS:NYSE), 79.06%
- Motorsport Games Inc. (MSGM:NASDAQ), 67.47%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 56.34%
- Viveve Medical, Inc. (VIVE:NASDAQ), 54.76%
- Longboard Pharmaceuticals Inc. (LBPH:NASDAQ), 49.39%
- iBio, Inc. (IBIO:NYSEMKT), 48.51%